Evidence map›Paper›PMID 34258250›Full record

ArticleJournal of cancer prevention2021

Protective Effects of Silibinin on

Kyunghwa Cho, Hee Geum Lee, Juan-Yu Piao, Su-Jung Kim, Hye-Kyung Na, Young-Joon Surh

Open access · diamondAbstract read
In one paragraph

Article in Journal of cancer prevention, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Research Status and Prospects ofGastroenterology research and practice · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. World journal of hepatology · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Silymarin and Inflammation: Food for Thoughts.Antioxidants (Basel, Switzerland) · 2024
    Review
  11. Review
  12. A review for non-antibiotic treatment ofFrontiers in microbiology · 2024
    Review
  13. Reactive Oxygen Species andAntioxidants (Basel, Switzerland) · 2023
    Review
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kyunghwa ChoResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea.ORCID https://orcid.org/0000-0002-6200-1071
Hee Geum LeeResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea.ORCID https://orcid.org/0000-0002-7877-9160
Juan-Yu PiaoResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea.ORCID https://orcid.org/0000-0001-6512-1370
Su-Jung KimResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea.ORCID https://orcid.org/0000-0002-3636-0644
Hye-Kyung NaDepartment of Food Science and Biotechnology, College of Knowledge-based Services Engineering, Sungshin Women's University, Seoul, Korea.ORCID https://orcid.org/0000-0003-0460-2810
Young-Joon SurhResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea.ORCID https://orcid.org/0000-0001-8310-1795
Seoul National University · KRSungshin Women's University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than half of the world's populations are considered to be infected by

Indexed as

GastritisHelicobacter pyloriNF-κBSilibininSTAT3

Identifiers

PMID34258250
PMCPMC8249208
OpenAlexW3181052314

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.